OABINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABIW
OmniAb, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.69+0.10 (+2.18%)
Close on Oct 19, 2026
- Market cap
- $604.05M
- P/E (TTM)
- –
- Dividend yield
- –
OmniAb, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| License and milestone revenue | $9.77M | $13.87M | $20.70M | $38.93M | $14.66M | 52.3% | -29.5% |
| Service revenue | $7.26M | $11.95M | $12.18M | $18.78M | $20.08M | 38.9% | -39.2% |
| Royalty revenue | $878.00K | $576.00K | $1.29M | $1.37M | $0 | 4.7% | +52.4% |
| xPloration revenue | $754.00K | $0 | – | – | – | 4.0% | – |
| License fees | – | – | – | $5.06M | $4.50M | – | – |
| Milestone revenue | – | – | – | $33.87M | $10.16M | – | – |
By region
From the segment and revenue-disaggregation notes of OmniAb's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.